Rapid HIV Antigen-Antibody Assays and Detection of Acute HIV Infection in Sub-Saharan Africa

Am J Trop Med Hyg. 2019 Aug;101(2):285-286. doi: 10.4269/ajtmh.19-0144.

Abstract

Detection of acute HIV infection is a unique problem that fourth-generation HIV assays were expected to alleviate. In this commentary, we draw attention to the limitations and challenges with use of currently available rapid antigen-antibody (Ag/Ab) combination tests for detection of acute HIV infection in sub-Saharan Africa. Laboratory-based HIV-1 Ag/Ab immunoassays are complex, requiring specialized equipment and handling that are currently not affordable in many settings in Africa. The point-of-care Ag/Ab platform on the other hand is easier to deploy and potentially more accessible in resource-limited settings. However, available fourth-generation HIV-1 rapid diagnostic tests have demonstrated poor performance characteristics in field studies where non-B subtypes of HIV-1 dominate. The potential for point-of-care HIV-1 Ag/Ab diagnostics to significantly improve detection of acute HIV infection remains yet to be realized in sub-Saharan Africa. Assay platforms need to be optimized to identify local circulating subtypes, and optimal algorithms need to be determined.

MeSH terms

  • Acute Disease
  • Africa South of the Sahara
  • HIV
  • HIV Antibodies / blood*
  • HIV Infections / diagnosis*
  • HIV Infections / virology
  • Humans
  • Mass Screening
  • Point-of-Care Systems
  • Sensitivity and Specificity
  • Serologic Tests*

Substances

  • HIV Antibodies